Five germline and two somatic mutations identified following a screen of exons 16-40 using SSCP/HA
Patient ID | Somatic or germline | Mutation | Exon/intron | Restriction site modification | Amino acid substitution/ predicted protein changes | |||||
BL7 | G | IVS 4+ 1 | Intron 4 | No change | ||||||
G→A | ||||||||||
BL22 | G | IVS17-2 | Intron 17 | No change | ||||||
G→A | ||||||||||
BL62 | G | 4024 del TA | Exon 23-1 | Gain Hpy178III site and loseHpy188IX | Premature stop at residue 1344 | |||||
BL17 | G | 5272 del C | Exon 29 | GainMseI,DraI | Premature stop at residue 1758 | |||||
BL23 | G | 7627 del AC | Exon 41 | GainDdeI | Premature stop at residue 2400 | |||||
T7 | S | R816X | Exon 16 | No change | Premature stop at residue 815 | |||||
CGA→TGA | ||||||||||
T52.1 | S | 7168delGA | Exon 40 | LoseHpy188IX,ApoI | Premature stop at residue |
S = somatic, G = germline, T = tumour, Bl = blood.